ISHARES TR's ticker is IBB and the CUSIP is 464287556. A total of 786 filers reported holding ISHARES TR in Q3 2020. The put-call ratio across all filers is 1.64 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $435 | -0.9% | 3,561 | +3.0% | 0.01% | +16.7% |
| Q2 2023 | $439 | -1.8% | 3,458 | 0.0% | 0.01% | -14.3% |
| Q1 2023 | $447 | -3.0% | 3,458 | -1.4% | 0.01% | +16.7% |
| Q4 2022 | $461 | -99.9% | 3,508 | 0.0% | 0.01% | -14.3% |
| Q3 2022 | $410,000 | +88.9% | 3,508 | +110.7% | 0.01% | +133.3% |
| Q1 2022 | $217,000 | -98.0% | 1,665 | -97.7% | 0.00% | -98.4% |
| Q4 2021 | $10,895,000 | +2737.2% | 71,386 | +2901.9% | 0.19% | +2628.6% |
| Q3 2021 | $384,000 | -7.2% | 2,378 | -5.9% | 0.01% | -12.5% |
| Q2 2021 | $414,000 | +12.2% | 2,528 | +3.1% | 0.01% | 0.0% |
| Q1 2021 | $369,000 | -35.3% | 2,453 | -34.8% | 0.01% | -38.5% |
| Q4 2020 | $570,000 | +71.7% | 3,765 | +53.5% | 0.01% | +44.4% |
| Q3 2020 | $332,000 | -0.9% | 2,453 | 0.0% | 0.01% | -10.0% |
| Q2 2020 | $335,000 | +53.7% | 2,453 | +20.0% | 0.01% | -16.7% |
| Q1 2018 | $218,000 | +847.8% | 2,045 | +2952.2% | 0.01% | +500.0% |
| Q4 2015 | $23,000 | – | 67 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Elliott Investment Management L.P. | 4,617,600 | $564,686,304 | 4.37% |
| BOULDER HILL CAPITAL MANAGEMENT LP | 57,250 | $7,001,103 | 4.35% |
| DAFNA Capital Management LLC | 102,500 | $12,534,725 | 3.90% |
| Michelson Medical Research Foundation, Inc. | 43,395 | $5,306,775 | 3.58% |
| Rye Brook Capital LLC | 40,900 | $5,002 | 3.56% |
| Bronte Capital Management Pty Ltd. | 283,229 | $34,636,074 | 3.49% |
| FWL INVESTMENT MANAGEMENT, LLC | 39,504 | $4,830,944 | 3.24% |
| Alpha Family Trust | 34,568 | $4,227,321 | 3.22% |
| HARBOUR INVESTMENT MANAGEMENT LLC | 40,720 | $4,985,830 | 2.85% |
| CUMBERLAND ADVISORS INC | 51,490 | $6,296,712 | 2.79% |